PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology.
Ontology highlight
ABSTRACT: The human epidermal growth factor receptor family (EGFR-family, other designations: HER family, RTK Class I) is strongly linked to oncogenic transformation. Its members are frequently overexpressed in cancer and have become attractive targets for cancer therapy. To ensure effective patient care, potential responders to HER-targeted therapy need to be identified. Radionuclide molecular imaging can be a key asset for the detection of overexpression of EGFR-family members. It meets the need for repeatable whole-body assessment of the molecular disease profile, solving problems of heterogeneity and expression alterations over time. Tracer development is a multifactorial process. The optimal tracer design depends on the application and the particular challenges of the molecular target (target e
SUBMITTER: Rinne SS
PROVIDER: S-EPMC8036874 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA